Posted Aug. 19, 2016 at 6:50 a.m.

Premium Lock Mayne Pharma's $50M GSK deal; UNC-CH opioid drug project; SAS targets heat, disease; RTI's $2M biofuels deal

Published: 2016-08-19 06:50:15
Updated: 2016-08-19 06:50:15

Triangle headlines Triangle headlines

In today's wrapup of tech and life science headlines from around the Triangle region: Mayne Pharma spends $50 million to acquire some GSK dermatology assets; UNC-CH researchers help develop an opioid drug candidate from scratch; SAS works with an Arizona county to fight heat and disease; and RTI International lands a $2M-plus biofuels contract....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders